Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for preventing and treating rheumatoid arthritis

A composition, arthritic technology, applied in the directions of drug combinations, antipyretics, anti-inflammatory agents, etc., can solve problems such as harm, interference with innate immunity and adaptive immunity, etc.

Inactive Publication Date: 2011-11-09
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, any of the regulatory pathways targeted by biological agents also play a key role in normal cells, and interfering with these regulatory pathways has potential harm to the body's innate and adaptive immunity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for preventing and treating rheumatoid arthritis
  • Pharmaceutical composition for preventing and treating rheumatoid arthritis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Embodiment 1 Pharmacological experiment of the present invention

[0025] Experimental Materials

[0026] Drugs and Reagents

[0027] Chicken type II collagen (CII): Chondrex, Redmond, WA 98052, USA; Incomplete Freund's Adjuvant (IFA) Difco Laboratories, Detroit, MI; Phosphate buffered saline (PBS): self-prepared by our laboratory, in 800ml Dissolve 8gNaCl, 0.2g KCl, 1.44gNa in distilled water 2 HPO 4 and 0.24gKH 2 PO 4 . Use hydrochloric acid to adjust the pH to 7.4, add water to make up to 1L, filter and sterilize before use; Dimethyl sulfoxide (DMSO) is a product of Sigma Company; 1640 medium: Jinuo Biomedical Technology Co., Ltd.; Calf Serum: Minhai Biological Co., Ltd.; 96-well flat bottom plate, CORNING; 70 μm cell grinding filter, BD Falcon; 15ml, 50ml centrifuge tubes, BD Falcon; 0.22μm filter, Millipore; 1ml screw-top syringe, BD Braun tee, Braun company of Germany; Methotrexate sheet: Shanghai Pharmaceutical (Group) Co., Ltd. Xinyi Pharmaceutical Genera...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for preventing and treating rheumatoid arthritis. The traditional Chinese medicine raw materials for constituting active ingredients of the pharmaceutical composition by weight are as follows: 5.5-6.0mg of berberine, 0.3-0.4mg of palmatine, 1.5-2.0mg of jatrorrhizine, 1.5-1.8mg of magnoflorine, 0.1-0.2mg of phellodendrine, 0.2-0.3mg of coptisine, 55-60mg of baicalin, 1.5-2.0mg of baicalein, 5.0-7.0mg of wogonoside, 0.03-0.05mg of wogonin, 20-25mg of geniposide, 0.1-0.2mg of crocin and 0.25-0.3mg of chlorogenic acid. The results of pharmacological tests show that the pharmaceutical composition can significantly reduce the disease severity of CIA mice with the rheumatoid arthritis, significantly improve the inflammation and the immune injury situation at lesion sites in comparison with a control group and be used for preparing drugs for preventing and treating the rheumatoid arthritis.

Description

technical field [0001] The invention relates to traditional Chinese medicine, in particular to a pharmaceutical composition for preventing and treating rheumatoid arthritis. Background technique [0002] Rheumatoid arthritis (Rheumatoid arthritis) is a chronic systemic autoimmune autoimmune disease characterized by joint synovitis. Synovitis is persistent and recurrent, which can lead to the destruction of cartilage and bone in the joint, joint dysfunction, and even disability. It is a chronic systemic inflammatory disease of unknown etiology, with chronic, symmetrical, polysynovial arthritis and extra-articular lesions as the main clinical manifestations, and belongs to autoimmune inflammatory disease. It often occurs in small joints such as hands, wrists, and feet, and it is easy to recur and is symmetrically distributed. In the early stage, joints are red, swollen, hot, painful, and dysfunctional. In the late stage, joints may be stiff and deformed in varying degrees, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7048A61K31/4375A61K31/473A61K31/352A61K31/194A61K31/216A61P19/02A61P29/00
Inventor 张卫东窦圣姗柳润辉刘晓华单磊苏娟沈云亨李慧梁徐希科刘心如
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com